A clinical-stage biopharmaceutical company focused on developing small molecule therapeutics to restore neuronal health and slow neurodegradation, with a pipeline targeting neurodegenerative diseases including amyotrophic lateral sclerosis.
Bothell, WA, United States~19 employeesFounded Jan 2011Website